Deep Track Capital as of Dec. 31, 2023
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 58 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 5.5 | $166M | 5.4M | 30.99 | |
| Springworks Therapeutics (SWTX) | 5.0 | $148M | 4.1M | 36.50 | |
| Intra Cellular Therapies (ITCI) | 4.8 | $143M | 2.0M | 71.62 | |
| Cytokinetics Com New (CYTK) | 4.6 | $137M | 1.6M | 83.49 | |
| Guardant Health (GH) | 4.5 | $135M | 5.0M | 27.05 | |
| Argenx Se Sponsored Adr (ARGX) | 3.8 | $114M | 300k | 380.43 | |
| Alkermes SHS (ALKS) | 3.7 | $111M | 4.0M | 27.74 | |
| Pliant Therapeutics (PLRX) | 3.5 | $104M | 5.8M | 18.11 | |
| Dynavax Technologies Corp Com New (DVAX) | 3.3 | $99M | 7.1M | 13.98 | |
| Axsome Therapeutics (AXSM) | 2.7 | $80M | 1.0M | 79.59 | |
| Miragen Therapeutics (VRDN) | 2.6 | $79M | 3.6M | 21.78 | |
| Autolus Therapeutics Spon Ads (AUTL) | 2.6 | $76M | 12M | 6.44 | |
| Pacific Biosciences of California (PACB) | 2.3 | $69M | 7.0M | 9.81 | |
| Intellia Therapeutics (NTLA) | 2.3 | $69M | 2.3M | 30.49 | |
| Travere Therapeutics (TVTX) | 2.2 | $66M | 7.4M | 8.99 | |
| Apogee Therapeutics (APGE) | 2.2 | $65M | 2.3M | 27.94 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.1 | $63M | 3.2M | 19.88 | |
| Ionis Pharmaceuticals (IONS) | 2.1 | $63M | 1.2M | 50.59 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 2.1 | $63M | 3.5M | 18.08 | |
| Geron Corporation (GERN) | 2.1 | $62M | 30M | 2.11 | |
| Editas Medicine (EDIT) | 1.9 | $55M | 5.5M | 10.13 | |
| Ambrx Biopharma | 1.8 | $53M | 3.7M | 14.24 | |
| Sarepta Therapeutics (SRPT) | 1.6 | $48M | 500k | 96.43 | |
| Tourmaline Bio (TRML) | 1.6 | $48M | 1.8M | 26.18 | |
| Hillevax (HLVX) | 1.6 | $47M | 2.9M | 16.05 | |
| 4d Molecular Therapeutics In (FDMT) | 1.5 | $46M | 2.3M | 20.26 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.5 | $46M | 4.3M | 10.70 | |
| Rapt Therapeutics (RAPT) | 1.5 | $45M | 1.8M | 24.85 | |
| Anaptysbio Inc Common (ANAB) | 1.5 | $44M | 2.0M | 21.42 | |
| Immunovant (IMVT) | 1.4 | $42M | 1.0M | 42.13 | |
| Spyre Therapeutics Com New (SYRE) | 1.4 | $42M | 2.0M | 21.52 | |
| Ocular Therapeutix (OCUL) | 1.4 | $41M | 9.2M | 4.46 | |
| Arcellx Common Stock (ACLX) | 1.3 | $40M | 725k | 55.50 | |
| Terns Pharmaceuticals (TERN) | 1.3 | $40M | 6.1M | 6.49 | |
| Silence Therapeutics Ads (SLN) | 1.1 | $34M | 2.0M | 17.37 | |
| Orchard Therapeutics Spon Ads New | 1.1 | $34M | 2.0M | 16.45 | |
| Nuvalent Inc-a (NUVL) | 1.1 | $33M | 450k | 73.59 | |
| Biosante Pharmaceuticals (ANIP) | 1.1 | $33M | 600k | 55.14 | |
| Nurix Therapeutics (NRIX) | 1.0 | $31M | 3.0M | 10.32 | |
| Edgewise Therapeutics (EWTX) | 0.9 | $28M | 2.5M | 10.94 | |
| Prothena Corp SHS Put Option (PRTA) | 0.9 | $27M | 750k | 36.34 | |
| Olema Pharmaceuticals (OLMA) | 0.9 | $27M | 1.9M | 14.03 | |
| Dyne Therapeutics (DYN) | 0.9 | $27M | 2.0M | 13.30 | |
| Agenus Com New | 0.9 | $26M | 32M | 0.83 | |
| Agios Pharmaceuticals (AGIO) | 0.8 | $24M | 1.1M | 22.27 | |
| Repare Therapeutics Ord (RPTX) | 0.7 | $22M | 3.0M | 7.30 | |
| Scholar Rock Hldg Corp (SRRK) | 0.6 | $19M | 1.0M | 18.80 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $12M | 300k | 40.76 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.4 | $12M | 2.5M | 4.67 | |
| Nektar Therapeutics (NKTR) | 0.3 | $10M | 18M | 0.56 | |
| Relmada Therapeutics (RLMD) | 0.3 | $8.5M | 2.0M | 4.14 | |
| Allakos (ALLK) | 0.2 | $6.9M | 2.5M | 2.73 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.2 | $6.5M | 829k | 7.79 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $6.3M | 275k | 22.93 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.2 | $5.9M | 48k | 123.00 | |
| Vigil Neuroscience (VIGL) | 0.2 | $5.4M | 1.6M | 3.38 | |
| Aligos Therapeutics (ALGS) | 0.1 | $4.1M | 6.1M | 0.66 | |
| Gh Research Ordinary Shares (GHRS) | 0.1 | $2.9M | 499k | 5.80 |
